We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+9.11%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$10.9B
AUM Growth
+$354M
Cap. Flow
-$371M
Cap. Flow %
-3.39%
Top 10 Hldgs %
21.68%
Holding
2,365
New
95
Increased
251
Reduced
1,484
Closed
53

Sector Composition

Rank Sector Weight
1 Technology 20.23%
2 Financials 13.41%
3 Healthcare 12.54%
4 Consumer Discretionary 11.8%
5 Industrials 9.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LITS
2151
Lite Strategy Inc
LITS
$31.4M
$164K ﹤0.01%
2,396
+1,797
+300% +$126K
HAYN
2152
DELISTED
Haynes International, Inc.
HAYN
$164K ﹤0.01%
5,537
MCB icon
2153
Metropolitan Bank Holding Corp
MCB
$1.17B
$164K ﹤0.01%
+3,249
New +$150K
CIVB icon
2154
Civista Bancshares
CIVB
$597M
$163K ﹤0.01%
7,109
-1,080
-13% -$21.7K
DMRC icon
2155
Digimarc Corp
DMRC
$167M
$163K ﹤0.01%
5,494
FOR icon
2156
Forestar Group
FOR
$1.49B
$163K ﹤0.01%
6,983
VPG icon
2157
Vishay Precision Group
VPG
$934M
$162K ﹤0.01%
5,267
AKRO
2158
DELISTED
Akero Therapeutics
AKRO
$162K ﹤0.01%
5,589
SFST icon
2159
Southern First Bancshares
SFST
$607M
$161K ﹤0.01%
+3,434
New +$150K
UFPT icon
2160
UFP Technologies
UFPT
$2.5B
$161K ﹤0.01%
3,225
SYRE icon
2161
Spyre Therapeutics
SYRE
$9.18B
$161K ﹤0.01%
811
+491
+153% +$94.2K
DSKE
2162
DELISTED
Daseke, Inc. Common Stock
DSKE
$161K ﹤0.01%
18,908
-1,771
-9% -$10.9K
FC icon
2163
Franklin Covey
FC
$234M
$160K ﹤0.01%
5,658
KDMN
2164
DELISTED
Kadmon Holdings, Inc.
KDMN
$160K ﹤0.01%
41,078
-32,677
-44% -$150K
RBB icon
2165
RBB Bancorp
RBB
$462M
$159K ﹤0.01%
+7,829
New +$149K
UFI icon
2166
UNIFI
UFI
$127M
$159K ﹤0.01%
+5,755
New +$139K
BDSI
2167
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$159K ﹤0.01%
40,553
+21,720
+115% +$89.7K
INBK icon
2168
First Internet Bancorp
INBK
$255M
$158K ﹤0.01%
+4,476
New +$150K
CUE icon
2169
Cue Biopharma
CUE
$128M
$158K ﹤0.01%
430
+3
+0.7% +$1.24K
TELL
2170
DELISTED
Tellurian Inc.
TELL
$157K ﹤0.01%
+67,302
New +$184K
KALV
2171
DELISTED
KalVista Pharmaceuticals
KALV
$157K ﹤0.01%
6,130
-963
-14% -$25.3K
PLSE icon
2172
Pulse Biosciences
PLSE
$3.09B
$157K ﹤0.01%
6,647
BSRR icon
2173
Sierra Bancorp
BSRR
$528M
$157K ﹤0.01%
5,841
CHS
2174
DELISTED
Chicos FAS, Inc.
CHS
$157K ﹤0.01%
+47,282
New +$124K
INSG icon
2175
Inseego
INSG
$82.6M
$156K ﹤0.01%
1,562
-1,303
-45% -$190K

Similar funds

MetLife Investment Management's Q1 2021 Portfolio in Review

As of Q1 2021, MetLife Investment Management held 2,365 positions worth $10.9B, up 3.3% from $10.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

MetLife Investment Management withdrew a net $371M in Q1 2021, closing 53 positions and reducing 1,484 holdings. Its most notable exit was Plains All American Pipeline, an estimated $17.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.

Against the trend, MetLife Investment Management opened a new position in NXP Semiconductors worth $13.3M.

  • MetLife Investment Management's largest Q1 2021 buy was NXP Semiconductors: 66,011 shares worth $13.3M.
  • MetLife Investment Management added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q1 2021, an estimated $11.5M increase.
  • MetLife Investment Management's biggest Q1 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $65.3M.
  • MetLife Investment Management fully exited Plains All American Pipeline in Q1 2021, selling an estimated $17.4M.
  • MetLife Investment Management's ten largest holdings make up 22% of its $10.9B portfolio in Q1 2021.
  • MetLife Investment Management opened 95 new positions and closed 53 in Q1 2021.
  • MetLife Investment Management's portfolio value rose 3.3% quarter-over-quarter to $10.9B.

Based on MetLife Investment Management's 13F filing for Q1 2021, filed 14 May 2021.